Registration Details
The NC3Rs NAMs Network brings researchers, developers and industry and regulatory end-users together to accelerate the use of new approach methodologies*.
Our NAMs Network symposium aims to connect technology developers with industry end-users. We will share insights from first-hand experiences of the deployment of NAMs technologies and future opportunities to reduce the reliance on animal toxicity testing in human safety assessment. There will be presentations from NAMs experts, panel discussions, a brainstorming workshop and networking opportunities.
Registration details
Please note this event is exclusively for members of the NC3Rs NAMs Network. If you are interested in attending but are not currently a member, please join the Network before registering for the event.
Agenda
The full agenda will be confirmed in March.
Session 1: Learnings from the deployment of NAMs technologies
Technology developers from academia and SMEs will share their insights through presentations and a panel discussion.
- Dr Jillian Gahan, STEMCELL Technologies.
- Dr Amer Jamalpoor, Toxys.
- Dr Chris Kirton, Definigen.
- Ms Christine Schwenk, InSphero.
Session 2: Applying NAMs in industry settings
NAMs experts from industry and CROs will share their perspective of working with NAMs technologies through presentations and a panel discussion.
- Dr Anthony Lynch, GSK.
- Dr Rhiannon David, AstraZeneca.
- Dr Chris Cooper, Labcorp.
Session 3: Workshop – Sharing experiences and identifying opportunities to increase the uptake of NAMs
Opportunities for all attendees to discuss their experiences and insights of working in the NAMs space.
Session 4: Networking
* We use the term new approach methodologies specifically to refer to full and partial replacement approaches for assessing chemical or drug toxicity. Learn more on our page on NAMs terminology.